Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.61 | 0.03 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |